Join
Live feed
·
PRReleasevia Quantisnow
Veru Inc. logo

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

ByQuantisnow·Wall Street's wire, on your screen.
VERU· Veru Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERU (Veru Inc.) and more on Quantisnow.